These press releases are intended for business journalists
and analysts/investors.
30 January 2012
GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020
27 January 2012
GSK announces changes to the Board
09 January 2012
GSK and Theravance announce initial outcomes from pivotal Phase III studies for once-daily RelovairTM* in COPD and asthma
Investors